The global tinea pedis treatment market is on track for substantial growth, with projections indicating a rise from USD 1,496.3 million in 2024 to USD 2,484 million by 2034. This growth represents a ...
As is the case with many other germs these days, there are some drug-resistant cases of tinea related to overuse of antifungal medications. But the vast majority of fungal infections go away with ...